产前孕酮治疗对儿童发育、行为与健康的长期影响:系统综述
该系统综述检索MEDLINE、Embase和Cochrane Central Register of Controlled Trials(自建库至2020年5月24日),纳入5项随机对照试验的7篇文章,共4222次测量,儿童年龄6个月至8岁。所有研究均为孕中晚期孕酮与安慰剂对比预防早产。Meta分析(2项研究,n=890)显示2岁时Bayley-III认知复合评分无差异(SMD -0.04,95%CI -0.26至0.19),I2=22%。其他长期结局无差异。结论:未发现产前孕酮治疗对子代有益或有害的证据,但早孕期孕酮及儿童期后结局需进一步随访研究。
要点
- 孕中晚期孕酮预防早产对儿童2岁神经发育无显著影响。
- 其他长期结局(行为、健康)未见差异,但异质性限制合并分析。
- 早孕期孕酮暴露及儿童期后结局证据缺乏,需随访研究。
核心结论
- 产前孕酮治疗(孕中晚期预防早产)对子代发育、行为与健康未见明确受益或危害证据。
- 早孕期孕酮暴露及儿童期后结局尚不明确,需进一步随访研究。
研究设计与样本
- 系统综述纳入5项随机对照试验的7篇文章,共4222次儿童测量,年龄6个月至8岁。
- 所有研究均为孕中晚期孕酮与安慰剂对比预防早产。
- 检索MEDLINE、Embase和Cochrane Central Register of Controlled Trials自建库至2020年5月24日。
主要发现
- Meta分析(2项研究,n=890)显示2岁时Bayley-III认知复合评分无差异(SMD -0.04,95%CI -0.26至0.19),I2=22%。
- 其他长期结局未见差异,但异质性限制进一步Meta分析。
临床怎么用
- 产前孕酮用于预防早产时,现有证据未提示对子代发育、行为与健康有明确长期危害。
- 早孕期孕酮暴露的长期结局证据不足,临床决策需个体化并关注后续随访。
局限性
- 纳入研究均针对孕中晚期预防早产,早孕期孕酮暴露证据缺乏。
- 随访年龄范围6个月至8岁,儿童期后结局未知。
- 异质性限制Meta分析,仅2项研究可合并。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Progesterone is widely used in prenatal care. However, long-term effects of prenatal progesterone treatment on child development are unclear. OBJECTIVES: To evaluate long-term outcomes in children after prenatal progesterone treatment. SEARCH STRATEGY: MEDLINE, Embase and Cochrane Central Register of Controlled Trials from inception to 24 May 2020. SELECTION CRITERIA: Randomised controlled trials (RCTs) reporting outcomes in children born to women who received progesterone treatment (compared with placebo or another intervention) during any trimester in pregnancy. DATA COLLECTION AND ANALYSIS: Two authors independently selected and extracted data. We used the Cochrane Risk of Bias tool for randomised trials and Quality In Prognosis Studies. MAIN RESULTS: Of 388 papers, we included seven articles based on five RCTs, comprising 4222 measurements of children aged 6 months to 8 years. All studies compared progesterone to placebo in second and/or third trimester for the prevention of preterm birth. Meta-analysis (two studies, n = 890 children) showed no difference in neurodevelopment as assessed by the Bayley-III Cognitive Composite score at 2 years between children exposed to progesterone versus placebo (Standardised Mean Difference -0.04, 95% Confidence Interval -0.26 to 0.19), I2 = 22%. Heterogeneity prohibited additional meta-analyses. Other long-term outcomes showed no differences. CONCLUSIONS: Our systematic review comprising a multitude of developmental measurements with a broad age range did not find evidence of benefit or harm in offspring prenatally exposed to progesterone treatment for the prevention of preterm birth. We identified an urgent need for follow-up studies of prenatal progesterone administration in early pregnancy and effects in offspring beyond early childhood. TWEETABLE ABSTRACT: Progesterone to prevent preterm birth: no effect on child development. Outcomes after first trimester progesterone are unclear.
引用
- Simons NE, Leeuw M, Van't Hooft J, et al. The long-term effect of prenatal progesterone treatment on child development, behaviour and health: a systematic review. BJOG. 2020. PMID: 33112462. doi:10.1111/1471-0528.16582
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。